Latest Breaking News On - Sarah mccabe - Page 5 : comparemela.com

Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis

– Phase 1/2 trial for CABA-201 planned to initiate in patients with myositis at an initial dose that is equivalent to the dose used in a patient with myositis as reported in the recent. | May 16, 2023

United statesSteven nichtbergerSarah mccabeAnup mardaDrug administrationExchange commissionStern investor relations incCabaletta bio incLancet rheumatologyInvestigational new drugChief executive officerCabaletta bioPrivate securities litigation reform actOrphan drug designationFast track designationInvestor relations

Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting

PHILADELPHIA, May 02, 2023 Cabaletta Bio, Inc. , a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with. | May 2, 2023

United statesJinmin leeSarah mccabeJason pengLos angelesAnup mardaSamik basuDaniel nunezJenell volkovLos angeles convention centerCabaletta bio incPreclinical researchAmerican society of geneStern investor relations incExchange commissionChief scientific officer

Cabaletta Bio Receives FDA Fast Track Designation for CABA-201

PHILADELPHIA, May 01, 2023 Cabaletta Bio, Inc. , a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with. | May 1, 2023

United statesAnup mardaSarah mccabeDavidj changDrug administrationStern investor relations incExchange commissionCabaletta bio incFast track designationChief medical officerBiologics license applicationCabaletta bioPrivate securities litigation reform actNature medicineOrphan drug designationInvestor relations

Bicara Therapeutics Announces Oral Presentation of Head and Neck Cancer Dose Expansion Data from Phase 1/1b Study of BCA101 at Upcoming 2023 ASCO Annual Meeting

Bicara Therapeutics Announces Oral Presentation of Head and Neck Cancer Dose Expansion Data from Phase 1/1b Study of BCA101 at Upcoming 2023 ASCO Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesMccormick placeChris raileyGlennj hannaSarah mccabeAmerican society of clinical oncologyMccormick place convention centerStern investor relations incClinical oncologyAnnual meetingOral abstract sessionNeck cancerInvestor relations

Bicara Therapeutics Announces Publication in Cancer Research Describing Design and Characterization

CAMBRIDGE, Mass. (BUSINESS WIRE) Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced the publication of a manuscript in Cancer Research, a journal of the American Association for Cancer Research (AACR), describ.

United statesUnited kingdomRachel salazarSarah mccabePradip nairChris raileyAmerican association for cancer researchSyngene internationalStern investor relations incCancer researchBicara therapeuticsAmerican associationAssociate research directorInvestor relations